|
|
| |
 |
Grants 2003 - 2004 |
|
| |
Burn Vac (Sponsor: KCI)
The Use of the Burn Vac in Hand Burn Injury
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: CLOSED |
| |
Flammacerium (Sponsor: Synthes)
Cerium Nitrate/Silver Sulfadiazine Cream vs Silver Sulfadiazine Cream Alone in the Treatment of Burn Patients
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: OPEN |
| |
MerckDiabetic SST (Sponsor: Merck)
A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in Adults
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: CLOSED |
| |
Baxter Fibrin Sealant (Sponsor: Baxter)
Protocol 520001: A study to assess the safety and efficacy of fibrin sealant (FS41U) for wound healing in subjects with burn wounds requiring skin grafting procedures
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: CLOSED |
| |
Merck IA (Sponsor: Merck)
A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Intra-abdominal Infections in Hospitalized Adults
PI: Gonzalez
Co-Inv: Dyess, Luterman, Frye, Hodge, Rodning
Enrollment Status: CLOSED |
| |
Scirex (Sponsor: Suntory)
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of a-hANP Infusion (Carperitide for Injection: SUN 4936) in Patients with Acute Respiratory Distress Syndrome (ARDS)
PI: Luterman
Co-Inv: Gonzalez, Frye, Rodning
Enrollment Status: CLOSED |
| |
Merropenem (Sponsor: Astra-Zeneca)
A Phase II, Multicenter, Randomized, Double-Blind, Comparitive Trial of Intravenous MERREM (meropenem, ICI 194,660) vs PRIMAXIN (imipenem-cilastatin) in the Treatment of Hospitalized Subjects with Complicated Skin and Skin Structure Infections
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: CLOSED |
| |
Mediwound (Sponsor: Mediwound)
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: OPEN |
| |
Gallium Malltolate (Sponsor: Titan, Pharm.)
A Randomized, Serum Level Study Investigating the Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Patients with Various Refractory Malignancies
PI: Boullier
Enrollment Status: OPEN |
| |
(Sponsor: Pfizer)
Clinical Protocol for a Multiple-Dose, Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for the Treatment of Post-Surgical Pain from Laparoscopic Cholecystectomy Surgery
PI: Turk
Co-Inv: Hodge, Gonzalez
Enrollment Status: CLOSED |
| |
Prograf (Sponsor: Fujisawa)
A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (cyclosporine)/MMF in de novo Kidney Transplant Recipients
PI: Scantlebury
Co-Inv: Magnone, Bryant
Enrollment Status: CLOSED |
| |
Dori-O8 (Sponsor: Pennisula)
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous Doripenem with that of Meropenem in Complicated Intra-abdominal Infections.
PI: Luterman
Co-Inv: LoCicero, Gonzalez, Rodning, Frye, Dyess, Hodge
Enrollment Status: Open post startup meeting |
| |
Dori-O6 (Sponsor: Pennisula)
A Multicenter, Phase 3 Study to Confirm the Safety and Efficacy of Intravenous Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis.
PI: Boullier
Co-Inv: Luterman, Hodge
Enrollment Status: Open post final contract signature |
| |
EPO (Sponsor: CareStat)
A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy And Safety of Epoetin Alfa in Critically III Subjects
PI: Luterman
Co-Inv: LoCicero, Gonzalez, Rodning, Frye, Dyess, Hodge
Enrollment Status: Open post startup visit |
| |
Fibrin Sealant (Sponsor: Baxter)
A Study to Evaluate the Safety and Efficacy of Fibrin Sealant with 4IU/ML Thrombin Vapor Heated, Solvent/Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
PI: Luterman
Co-Inv: Frye, Dyess
Enrollment Status: OPEN
|
| |
Levo (Sponsor: Ortho-McNeil)
A Multicenter, Open-label, Randomized Study to Compare the Safety and Efficacy of Once Daily Levofloxacin along with Once Daily Metronidazole Versus Piperacillin/tazobactam in the Treatment of Complicated Appendicitis
PI: Hodge
Co-Inv: LoCicero, Gonzalez, Rodning, Dyess, Luterman
Enrollment Status: OPEN
|
| |
Omeprazole (Sponsor: Kendle)
A Comparison of Omeprazole Sodium Bicarbonate Immediate-Release Powder for Suspension to Intravenous Cimetidine for the Prevention of Upper Gastrointestinal Bleeding in Critically III Patients
PI: Gonzalez
Co-Inv: LoCicero, Luterman, Rodning, Hodge
Enrollment Status: CLOSED |
| |
ARDS (Sponsor: Discovery Labs)
A Multicenter, Randomized, Controlled Trial Comparing The Safety And Effectiveness Of Surfaxin@ (Lucinactant) Delivered Via
Bronchopulmonary Segmental Lavage To Standard Of Care In Patients With Acute Respiratory Distress Syndrome (Ards)
PI: Gonzalez
Co-Inv: LoCicero, Luterman, Rodning, Dyess, Dodge
Enrollment Status: Open post final contract signature |
| |
Wyeth 307 (Sponsor: Wyeth)
A Phase 3, Multicenter, Double-Blind, Randomized (3:1) Study Evaluating Tigecycline & Linezolid For The Treatment Of Selected Serious Infections In Subjects With Vancomycin-Resistant Enterococcus (Vre) And Evaluating Tigecycline & Vancomycin For The Treatment Of Selected Serious Infections In Subjects With Methici1lin-Resistant Staphylococcus Aureus (Mrsa)
PI: Luterman
Co-Inv: LoCicero, Gonzalez, Rodning, Dyess, Dodge
Enrollment Status: Open post startup meeting July 2Oth |
| |
Wyeth 309 (Sponsor: Wyeth)
A Phase 3, Open-Label, Noncomparative Study Of Tigecycline For The Treatment Of Subjects With Selected Serious Infections Due To Resistant Gram-Negative Organisms Such As Enterobacter Species, Acinetobacter Baumannii, And Klebsiella Pneumoniae
PI: Luterman
Co-Inv: LoCicero, Gonzalez, Rodning, Dyess, Dodge
Enrollment Status: Open post startup meeting July 2Oth
|
| |
EVCL (Sponsor: Lilly)
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Early Stage Severe Sepsis
PI: Gonzalez
Co-Inv: LoCicero, Luterman, Rodning, Dodge
Enrollment Status: CLOSED
|
| |
Xuess (Sponsor: Lilly)
An Observational Study Assessing the Use of Xigris on Adult Patients with Severe Sepsis
PI: LoCicero
Co-Inv: Gonzalez, Rodning, Dodge
Enrollment Status: CLOSED |
| |
| |
| |
LINKS |
| |
| New
IRB Initiatives |
| |
| Global
Research |
| |
| USA
Clinical Research |
| |
| |
|
|
| |
|
|
